Victoria P. Werth

Dr. Victoria P. Werth

Dermatology
3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
On Staff At
Accepting New Patients
Offers Telehealth
3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Victoria Werth, MD is a Dermatologist in Philadelphia, PA and has over 42 years of experience in the medical field. She graduated from Johns Hopkins School of Medicine in 1980. She is affiliated with Hospital of the University of Pennsylvania.

Dr. Werth is rated as an Experienced provider by MediFind in the treatment of 2q37 Deletion Syndrome. Her top areas of expertise are Cutaneous Lupus Erythematosus (CLE), Dermatomyositis, Discoid Lupus Erythematosus (DLE), and Pemphigus.

Her clinical research consists of co-authoring 479 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Johns Hopkins University School Of Medicine
Residency
Northwestern Medical Center
Specialties
Dermatology
Licenses
Dermatology in PA
Board Certifications
Dermatology - Dermatopathology, 1989
Dermatology, 1986
Internal Medicine, 1983
Hospital Affiliations
Hospital Of The University Of Pennsylvania
Languages Spoken
English
Gender
Female
Awards
Recognized annually in Philadelphia magazine's Top Docs issue from 2015 through 2025

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Penn Dermatology Perelman
3400 Civic Center Boulevard, South Pavilion, 1st Floor, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Werth has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pemphigus Vulgaris
Discoid Lupus Erythematosus (DLE)
Scleroderma
Bullous Pemphigoid
Epidermolysis Bullosa
Cicatricial Pemphigoid
Systemic Sclerosis (SSc)
Sjogren Syndrome
Dermatomyositis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug, Other
Study Drug: VIB7734
Study Phase: Phase 2
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Enrollment Status: Completed
Publish Date: July 13, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

478 Total Publications

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
Journal: The Journal of rheumatology
Published: December 01, 2025
Similar Doctors
Experienced in 2q37 Deletion Syndrome
Dr. Patrice Hyde
Dermatology | Pediatrics
Experienced in 2q37 Deletion Syndrome
Dr. Patrice Hyde
Dermatology | Pediatrics
833 Chestnut St, Suite 740, 
Philadelphia, PA 
 (2.0 miles away)
215-955-6680
Languages Spoken:
English
See accepted insurances

Patrice Hyde is a Dermatologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Hyde is rated as an Advanced provider by MediFind in the treatment of 2q37 Deletion Syndrome. Her top areas of expertise are Linear Hamartoma Syndrome, Stork Bite, Familial Multiple Nevi Flammei, and Vascular Birthmark.

Experienced in 2q37 Deletion Syndrome
Dr. Donald J. Baker
Dermatology
Experienced in 2q37 Deletion Syndrome
Dr. Donald J. Baker
Dermatology

Cmc Dept Of Medicine Group PA

2 Cooper Plz, 
Camden, NJ 
 (4.2 miles away)
855-632-2667
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Donald Baker is a Dermatologist in Camden, New Jersey. Dr. Baker is rated as an Advanced provider by MediFind in the treatment of 2q37 Deletion Syndrome. His top areas of expertise are Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Neurocutaneous Melanosis. Dr. Baker is currently accepting new patients.

Experienced in 2q37 Deletion Syndrome
Dr. Emily Y. Chu
Dermatology
Experienced in 2q37 Deletion Syndrome
Dr. Emily Y. Chu
Dermatology

Penn Dermatology Perelman

3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
 (0.1 miles away)
215-662-2737
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Emily Chu is a Dermatologist in Philadelphia, Pennsylvania. Dr. Chu is rated as a Distinguished provider by MediFind in the treatment of 2q37 Deletion Syndrome. Her top areas of expertise are Bowen's Disease, Warts, Melanoma, and Actinic Keratosis. Dr. Chu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Werth's expertise for a condition
ConditionClose
View All 9 Elite Conditions
View All 14 Advanced Conditions
View All 46 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile